Nasdaq Ifrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ifrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ifrx Today - Breaking & Trending Today

InflaRx (NASDAQ:IFRX) Short Interest Update

InflaRx (NASDAQ:IFRX – Get Free Report) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 672,500 shares, an increase of 298.9% from the October 31st total of 168,600 shares. Based on an average daily trading volume, of 314,100 shares, the short-interest ratio is […] ....

United States , Raymond James , Raymond James Financial Services Advisors Inc , Raymond James Associates , Affinity Asset Advisors , Inflarx Company Profile , Alps Advisors Inc , Get Free Report , Capital Investment Management , James Financial Services Advisors , Asset Advisors , Inflarx Daily , Nasdaq Ifrx ,

InflaRx (NASDAQ:IFRX) Given New $19.00 Price Target at Raymond James

InflaRx (NASDAQ:IFRX – Get Free Report) had its target price decreased by Raymond James from $21.00 to $19.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “strong-buy” rating on the stock. Separately, HC Wainwright restated a “buy” rating and set a $9.00 price target on shares of […] ....

United States , Raymond James , Virtu Financial , Prelude Capital Management , Jpmorgan Chase Co , Inflarx Company Profile , Geode Capital Management , Get Free Report , Capital Management , Inflarx Daily , Nasdaq Ifrx , Lower Price Target ,

InflaRx (NASDAQ:IFRX) Price Target Cut to $19.00 by Analysts at Raymond James

InflaRx (NASDAQ:IFRX – Free Report) had its price objective decreased by Raymond James from $21.00 to $19.00 in a report issued on Thursday morning, Benzinga reports. Raymond James currently has a strong-buy rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $9.00 target price on shares of InflaRx in a […] ....

United States , Raymond James , Invesco Ltd , Renaissance Technologies , Raymond James Financial Services Advisors Inc , Virtu Financial , Free Report , Get Free Report , James Financial Services Advisors , Montreal Can , Inflarx Daily , Nasdaq Ifrx , Lower Price Target ,

InflaRx's (IFRX) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $9.00 price target on the stock. InflaRx Trading Down 2.1 % Shares of InflaRx stock opened at $3.78 on Tuesday. The business’s fifty day simple moving […] ....

United States , Virtu Financial , Suvretta Capital Management , Jpmorgan Chase Co , Affinity Asset Advisors , Free Report , Asset Advisors , Capital Management , Get Free Report , Inflarx Daily , Nasdaq Ifrx , Reiterated Rating , Hc Wainwright ,

InflaRx (NASDAQ:IFRX) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a report published on Thursday, Benzinga reports. They currently have a $9.00 target price on the stock. InflaRx Trading Up 5.1 % IFRX opened at $4.15 on Thursday. The firm has a market capitalization of $185.52 million, a PE ratio […] ....

United States , Raymond James Associates , Jpmorgan Chase Co , Virtu Financial , Kestra Advisory Services , Free Report , Advisory Services , Raymond James , Get Free Report , Inflarx Daily , Nasdaq Ifrx , Reiterated Rating , Hc Wainwright ,